Predictors of failure on second-line antiretroviral therapy with protease inhibitor mutations in Uganda

INTRODUCTION: Failure on second-line antiretroviral therapy (ART) with protease inhibitor (PI) mutations (VF-M) is on the rise. However, there is a paucity of information on the factors associated with this observation in low-income countries. Knowledge of underlying factors is critical if we are to...

Descripción completa

Detalles Bibliográficos
Autores principales: Musana, Hellen, Ssensamba, Jude Thaddeus, Nakafeero, Mary, Mugerwa, Henry, Kiweewa, Flavia Matovu, Serwadda, David, Ssali, Francis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059285/
https://www.ncbi.nlm.nih.gov/pubmed/33882938
http://dx.doi.org/10.1186/s12981-021-00338-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059285/
https://www.ncbi.nlm.nih.gov/pubmed/33882938
http://dx.doi.org/10.1186/s12981-021-00338-y

Ejemplares similares